{"schema_version":"secwatch.filing_event.v1","accession":"0001323885-23-000045","form_type":"8-K","ticker":"ATRC","cik":"0001323885","company_name":"AtriCure, Inc.","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.381671+00:00","generated_at":"2026-06-16T02:56:35.540180+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AtriCure Q1 revenue $93.5M (+25.4% YoY), net loss narrows to $6.5M, positive adj. EBITDA $1.9M","bullets":["Revenue $93.5M (+25.4% YoY); US $78.2M (+25.6%), Intl $15.3M (+24.4%).","Net loss $6.5M improved $8.7M YoY; diluted EPS loss $0.14 vs $0.33.","Adjusted EBITDA positive $1.9M vs negative $4.2M in prior year.","FY 2023 revenue guidance $385-392M (17-19% growth); adj. EBITDA ~$2M; adj. EPS loss $1.10-$1.15.","Gross margin 74.5% flat YoY; operating loss $5.8M improved from $14.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0001323885-23-000045","json":"https://secwatch.observer/filing/0001323885-23-000045.json","markdown":"https://secwatch.observer/filing/0001323885-23-000045.md","text":"https://secwatch.observer/filing/0001323885-23-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1323885/000132388523000045/0001323885-23-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1323885/000132388523000045/atrc-20230502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T02:56:35.540180+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}